Sally Adams
Director/Board Member at Scancell Ltd.
Net worth: 8 792 $ as of 2024-04-29
Profile
Sally Elizabeth Adams is currently a Director & Development Director at Scancell Ltd.
She previously worked as an Executive Director & Chief Development Officer at Scancell Holdings Plc, a Development Director at Neures Ltd., and Head-Neurology & Virology at Ligand UK Ltd.
Adams holds a doctorate from Imperial College London and a graduate degree from the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SCANCELL HOLDINGS PLC
0.01% | 2023-12-18 | 78,714 ( 0.01% ) | 8 792 $ | 2024-04-29 |
Sally Adams active positions
| Companies | Position | Start |
|---|---|---|
Scancell Ltd.
 Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | - |
Former positions of Sally Adams
| Companies | Position | End |
|---|---|---|
| SCANCELL HOLDINGS PLC | Director/Board Member | 2024-02-04 |
| VERNALIS | Corporate Officer/Principal | - |
| Neures Ltd. | Corporate Officer/Principal | - |
Training of Sally Adams
| Imperial College London | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCANCELL HOLDINGS PLC | Health Technology |
| Private companies | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
| Neures Ltd. |
- Stock Market
- Insiders
- Sally Adams
